David W. Eyre

Overview

Best Publications

• Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.

  Erik Volz;Swapnil Mishra;Meera Chand;Jeffrey C. Barrett

  1164
  Citations

• Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

  Timothy M. Walker;Camilla L.C. Ip;Ruth H. Harrell;Jason T. Evans

  1076
  Citations

• SARS-CoV-2 evolution during treatment of chronic infection.

  Steven A. Kemp;Dami A. Collier;Dami A. Collier;Rawlings P. Datir;Isabella A. T. M. Ferreira

  973
  Citations

• Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

  S F Lumley;D O'Donnell;N E Stoesser;P C Matthews

  960
  Citations

• Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing

  D W Eyre;M L Cule;D J Wilson;D Griffiths

  749
  Citations

• COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.

  Victoria Jane Hall;Victoria Jane Hall;Sarah Foulkes;Ayoub Saei;Nick Andrews;Nick Andrews

  743
  Citations

• SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).

  V J Hall;S Foulkes;A Charlett;A Atti

  690
  Citations

• Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

  Dami A. Collier;Dami A. Collier;Anna De Marco;Isabella A. T. M. Ferreira;Bo Meng

  656
  Citations

• Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.

  Koen B. Pouwels;Koen B. Pouwels;Emma Pritchard;Emma Pritchard;Philippa C. Matthews;Philippa C. Matthews;Philippa C. Matthews;Nicole Stoesser

  502
  Citations

• Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.

  Katherine A Twohig;Tommy Nyberg;Asad Zaidi;Simon Thelwall

  501
  Citations

• A Candida auris Outbreak and Its Control in an Intensive Care Setting.

  David W Eyre;Anna E Sheppard;Hilary Madder;Ian Moir

  491
  Citations

• Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.

  Bo Meng;Steven A Kemp;Steven A Kemp;Guido Papa;Rawlings Datir

  413
  Citations

• Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018

  David W. Eyre;Nicholas D. Sanderson;Emily Lord;Natasha Regisford-Reimmer

  379
  Citations

• Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

  M Ainsworth;M Andersson;M Andersson;K Auckland;J K Baillie

  367
  Citations

• Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data.

  N. Stoesser;E. M. Batty;D. W. Eyre;M. Morgan

  347
  Citations

• SARS-CoV-2 within-host diversity and transmission.

  Katrina A Lythgoe;Matthew Hall;Luca Ferretti;Mariateresa de Cesare

  344
  Citations

• Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.

  Emma Pritchard;Emma Pritchard;Philippa C. Matthews;Philippa C. Matthews;Nicole Stoesser;David W. Eyre

  333
  Citations

• Effects of control interventions on Clostridium difficile infection in England: an observational study

  Kate E Dingle;Kate E Dingle;Kate E Dingle;Xavier Didelot;T Phuong Quan;T Phuong Quan;T Phuong Quan;David W Eyre;David W Eyre

  329
  Citations

• Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

  R P Payne;S Longet;J A Austin;D T Skelly

  321
  Citations

• A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance

  D W Eyre;T Golubchik;N C Gordon;R Bowden

  295
  Citations